Assembly Biosciences, Inc. Shareholders' Equity
Assembly Biosciences, Inc. (ASMB) had Shareholders' Equity of $305.65 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $305.65M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $198.61M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $206.75M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $182.69M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $305.65M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $198.61M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $206.75M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $182.69M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $18.10M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $27.13M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $33.36M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $26.00M 10-Q · filed 2025-11-10 | |
| 2024-06-30 | $34.68M 10-Q · filed 2025-11-10 | |
| 2024-03-31 | $32.60M 10-Q · filed 2025-08-06 | |
| 2023-12-31 | $41.10M 10-K · filed 2026-03-19 | |
| 2023-09-30 | $41.71M 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $54.95M 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $70.33M 10-Q · filed 2024-08-08 | |
| 2022-12-31 | $82.66M 10-K · filed 2025-03-20 | |
| 2022-09-30 | $102.40M 10-Q · filed 2023-11-08 | |
| 2022-06-30 | $123.98M 10-Q · filed 2023-11-08 | |
| 2022-03-31 | $146.79M 10-Q · filed 2023-08-09 | |
| 2021-12-31 | $168.93M 10-K · filed 2024-03-28 | |
| 2021-09-30 | $224.65M 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $231.79M 10-Q · filed 2022-11-08 | |
| 2021-03-31 | $247.24M 10-Q · filed 2022-08-09 | |
| 2020-12-31 | $240.58M 10-K · filed 2023-03-22 | |
| 2020-09-30 | $270.55M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $267.12M 10-Q · filed 2021-11-04 | |
| 2020-03-31 | $251.77M 10-Q · filed 2021-08-05 | |
| 2019-12-31 | $273.22M 10-K · filed 2022-03-11 | |
| 2019-09-30 | $156.49M 10-Q · filed 2020-11-05 | |
| 2019-06-30 | $174.71M 10-Q · filed 2020-11-05 | |
| 2019-03-31 | $190.40M 10-Q · filed 2020-08-05 | |
| 2018-12-31 | $210.65M 10-K · filed 2021-02-25 | |
| 2018-09-30 | $229.43M 10-Q · filed 2019-11-07 | $229.43M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $89.10M 10-Q · filed 2019-11-07 | $89.10M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $102.38M 10-Q · filed 2019-08-05 | $102.38M 10-Q · filed 2018-05-07 |
| 2017-12-31 | $113.12M 10-K · filed 2021-02-25 | $113.12M 10-K · filed 2018-03-08 |
| 2017-09-30 | $47.13M 10-Q · filed 2017-11-01 | |
| 2017-06-30 | $56.54M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $67.89M 10-Q · filed 2017-05-08 | |
| 2016-12-31 | $79.88M 10-K · filed 2020-03-04 | $79.88M 10-K · filed 2017-03-02 |
| 2016-09-30 | $90.04M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $100.56M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $109.28M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $118.74M 10-K · filed 2019-02-28 | $118.74M 10-K · filed 2016-03-11 |
| 2015-09-30 | $125.40M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $130.87M 10-Q · filed 2015-08-13 | |
| 2015-03-31 | $124.62M 10-Q · filed 2015-05-08 | |
| 2014-12-31 | $58.57M 10-K · filed 2018-03-08 | |
| 2014-09-30 | $47.20M 10-Q · filed 2014-11-17 | |
| 2014-06-30 | $20.29M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $22.44M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $24.49M 10-K · filed 2017-03-02 | |
| 2013-09-30 | $30.05M 10-Q · filed 2013-11-12 | |
| 2013-06-30 | $31.09M 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $35.13M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $17.81M 10-K · filed 2015-03-16 | |
| 2012-09-30 | $21.00M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $25.62M 10-Q · filed 2012-08-09 | |
| 2012-03-31 | $27.54M 10-Q · filed 2012-05-09 | |
| 2011-12-31 | $34.53M 10-K · filed 2014-03-31 | |
| 2011-09-30 | $52.21M 10-Q/A · filed 2011-11-18 | |
| 2011-06-30 | $9.43M 10-Q · filed 2011-08-15 | |
| 2010-12-31 | $11.63M 10-K · filed 2014-03-31 | |
| 2009-12-31 | -$13.36M 10-K · filed 2014-03-31 | |
| 2008-12-31 | -$9.46M 10-K · filed 2014-03-31 | |
| 2007-12-31 | -$4.38M 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| PUMA BIOTECHNOLOGY, INC. (PBYI) | United States | $0.507B | 15.53 |
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |